Clinical Trial Update: Temozolomide and Interferon Alfa in Treating Patients With Stage III or Stage IV Melanoma [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating temozolomide plus interferon alfa in patients with stage III or stage IV melanoma, including intraocular and cutaneous melanoma. The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Melanoma
• Intraocular Melanoma

Drugs mentioned

• Intron A (interferon alfa-2b)
• Temodar (Temozolomide)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Intraocular Melanoma, Melanoma (Skin) | Phase 2 | Status: COMPLETED